✦ LIBER ✦

A modular Phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapy

✍ Scribed by P. Mathew; N. Tannir; S. M. Tu; C. M. Carter; N. B. Bekele; L. Pagliaro

Book ID: 105993370
Publisher: Springer
Year: 2010
Tongue: English
Weight: 151 KB
Volume: 65
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-1237-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ixabepilone, mitoxantrone, and prednison

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy : A phase 2 study of the department of defense prostate cancer clinical trials consortium

✍ Andrea L. Harzstark; Jonathan E. Rosenberg; Vivian K. Weinberg; Jeremy Sharib; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

A phase I study of oral panobinostat alo

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

✍ Dana Rathkopf; Bryan Y. Wong; Robert W. Ross; Aseem Anand; Erika Tanaka; Margare 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 378 KB

A phase I study of combined docetaxel an

A phase I study of combined docetaxel and repeated high activity186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)

✍ Joyce M. van Dodewaard-de Jong; John M. H. de Klerk; Haiko J. Bloemendal; Bart P 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 136 KB